[go: up one dir, main page]

FI103111B1 - Menetelmä proteolyyttisen entsyymin inhibiittoreina käyttökelpoisten sakkariinijohdannaisten valmistamiseksi - Google Patents

Menetelmä proteolyyttisen entsyymin inhibiittoreina käyttökelpoisten sakkariinijohdannaisten valmistamiseksi

Info

Publication number
FI103111B1
FI103111B1 FI915093A FI915093A FI103111B1 FI 103111 B1 FI103111 B1 FI 103111B1 FI 915093 A FI915093 A FI 915093A FI 915093 A FI915093 A FI 915093A FI 103111 B1 FI103111 B1 FI 103111B1
Authority
FI
Finland
Prior art keywords
proteolytic enzyme
inhibitors
preparation
derivatives useful
saccharin derivatives
Prior art date
Application number
FI915093A
Other languages
English (en)
Swedish (sv)
Other versions
FI103111B (fi
FI915093A0 (fi
Inventor
Richard Paul Dunlap
Neil Warren Boaz
Albert Joseph Mura
Dennis John Hlasta
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of FI915093A0 publication Critical patent/FI915093A0/fi
Priority to FI944967A priority Critical patent/FI103113B1/fi
Priority to FI960488A priority patent/FI103114B/fi
Application granted granted Critical
Publication of FI103111B publication Critical patent/FI103111B/fi
Publication of FI103111B1 publication Critical patent/FI103111B1/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D275/00—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
    • C07D275/04—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D275/06—Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems with hetero atoms directly attached to the ring sulfur atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrrole Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FI915093A 1989-05-04 1991-10-29 Menetelmä proteolyyttisen entsyymin inhibiittoreina käyttökelpoisten sakkariinijohdannaisten valmistamiseksi FI103111B1 (fi)

Priority Applications (2)

Application Number Priority Date Filing Date Title
FI944967A FI103113B1 (fi) 1989-05-04 1994-10-21 Menetelmä proteolyyttisen entsyymin inhibiittoreina käyttökelpoisten sakkariinijohdannaisten valmistamiseksi
FI960488A FI103114B (fi) 1989-05-04 1996-02-02 Menetelmä proteolyyttisen entsyymin inhibiittoreina käyttökelpoisten s akkariinijohdannaisten valmistamiseksi

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US34712689A 1989-05-04 1989-05-04
US34712589A 1989-05-04 1989-05-04
US34712689 1989-05-04
US34712589 1989-05-04
US9002434 1990-05-01
PCT/US1990/002434 WO1990013549A1 (en) 1989-05-04 1990-05-01 Saccharin derivatives useful as proteolytic enzyme inhibitors and preparation thereof

Publications (3)

Publication Number Publication Date
FI915093A0 FI915093A0 (fi) 1991-10-29
FI103111B FI103111B (fi) 1999-04-30
FI103111B1 true FI103111B1 (fi) 1999-04-30

Family

ID=26995139

Family Applications (1)

Application Number Title Priority Date Filing Date
FI915093A FI103111B1 (fi) 1989-05-04 1991-10-29 Menetelmä proteolyyttisen entsyymin inhibiittoreina käyttökelpoisten sakkariinijohdannaisten valmistamiseksi

Country Status (17)

Country Link
EP (1) EP0471756B1 (fi)
JP (1) JPH04507095A (fi)
KR (1) KR0183397B1 (fi)
AT (1) ATE159720T1 (fi)
AU (1) AU637614B2 (fi)
DE (1) DE69031656T2 (fi)
DK (1) DK0471756T3 (fi)
ES (1) ES2110414T3 (fi)
FI (1) FI103111B1 (fi)
GR (1) GR1000965B (fi)
IL (1) IL94278A (fi)
MY (1) MY106202A (fi)
NO (1) NO300808B1 (fi)
NZ (1) NZ233521A (fi)
PT (1) PT93959B (fi)
SG (1) SG48298A1 (fi)
WO (1) WO1990013549A1 (fi)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5874424A (en) * 1995-12-20 1999-02-23 Vertex Pharmaceuticals Incorporated Inhibitors of interleukin-1β converting enzyme
US6204261B1 (en) 1995-12-20 2001-03-20 Vertex Pharmaceuticals Incorporated Inhibitors of interleukin-1β Converting enzyme inhibitors
US6008217A (en) * 1995-12-20 1999-12-28 Vertex Pharmaceuticals Incorporated Inhibitors of interleukin-1β converting enzyme
US5380737A (en) * 1989-05-04 1995-01-10 Sterling Winthrop Inc. Saccharin derivative proteolytic enzyme inhibitors
US5236917A (en) * 1989-05-04 1993-08-17 Sterling Winthrop Inc. Saccharin derivatives useful as proteolytic enzyme inhibitors and compositions and method of use thereof
US5512589A (en) * 1990-11-01 1996-04-30 Sterling Winthrop Inc. 2-saccharinylmethyl aryl carboxylates useful as proteolytic enzyme inhibitors and compositions and method of use thereof
AU642537B2 (en) * 1990-11-01 1993-10-21 Sanofi 2-saccharinylmethyl aryl carboxylates useful as proteolytic enzyme inhibitors and compositions and method of use thereof
US5250696A (en) * 1990-11-01 1993-10-05 Sterling Winthrop Inc. 2-saccharinylmethyl aryl carboxylate
US5306818A (en) * 1990-11-01 1994-04-26 Sterling Winthrop Inc. Tetrahydro 2-saccharinylmerthyl aryl carboxylates
AU656027B2 (en) * 1991-11-15 1995-01-19 Sanofi Saccharin derivative proteolytic enzime inhibitors
AU668694B2 (en) * 1991-12-19 1996-05-16 Sanofi-Synthelabo Saccharin derivative proteolytic enzyme inhibitors
US5378720A (en) * 1991-12-19 1995-01-03 Sterling Winthrop Inc. Saccharin derivative proteolytic enzyme inhibitors
US5187173A (en) * 1991-12-27 1993-02-16 Sterling Winthrop Inc. 2-saccharinylmethyl and 4,5,6,7-tetrahydro-2-saccharinylmethyl phosphates, phosphonates and phosphinates useful as proteolytic enzyme inhibitors and compositions and method of use thereof
US5296496A (en) * 1991-12-27 1994-03-22 Sterling Winthrop Inc. 2-saccharinylmethyl phosphates, phosphonates and phosphinates useful as proteolytic enzyme inhibitors and compositions and method of use thereof
TW226016B (fi) * 1991-12-30 1994-07-01 Sterling Winthrop Inc
AU653279B2 (en) * 1991-12-30 1994-09-22 Sanofi Novel 2-saccharinylmethyl heterocyclic carboxylates useful as proteolytic enzyme inhibitors and compositions and method of use thereof
DE4413951C1 (de) * 1994-04-21 1995-08-03 Cpc Maizena Gmbh Verfahren zur Herstellung einer Würzsoße
US6420522B1 (en) 1995-06-05 2002-07-16 Vertex Pharmaceuticals Incorporated Inhibitors of interleukin-1β converting enzyme
US5684195A (en) * 1994-07-14 1997-11-04 G. D. Searle & Co. Method of preparing sulfmonamides from sulfones
DE4427996A1 (de) * 1994-08-08 1996-02-15 Basf Ag Verfahren zur Herstellung von Saccharincarbonsäuren und -carbonsäureestern
US5494925A (en) * 1994-12-02 1996-02-27 Sterling Winthrop Inc. 2-heterocyclyloxymethyl and 2-heterocyclylthiomethyl-1,2,5-thiadiazolidin-3-one 1,1-dioxides and compositions and method of use thereof
US5843904A (en) * 1995-12-20 1998-12-01 Vertex Pharmaceuticals, Inc. Inhibitors of interleukin-1βconverting enzyme
CA2702950A1 (en) * 2007-10-16 2009-04-23 Northeastern University Methods and compounds for modulating cannabinoid activity

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1302858B (fi) * 1962-09-21 1972-05-04
JPS47419B1 (fi) * 1969-12-22 1972-01-07
US4195023A (en) * 1975-08-20 1980-03-25 Merck & Co., Inc. 2-(2-Furoyl)1,2-benzisothiazole-3-one, 2-(2-furoyl) saccharin, and 2-(2-thenoyl) saccharin
DE2800019A1 (de) * 1978-01-02 1979-07-12 Dynamit Nobel Ag N-halobenzyl-saccharine, ihre herstellung und verwendung
US4276298A (en) * 1978-03-24 1981-06-30 Merck & Co., Inc. 2-Aryl-1,2-benzisothiazolinone-1,1-dioxides and their use as selective protease inhibitors
US4350752A (en) * 1980-12-29 1982-09-21 Eastman Kodak Company Photographic elements and film units containing imidomethyl blocked photographic reagents
US4410618A (en) * 1982-06-11 1983-10-18 Eastman Kodak Company Blocked photographic reagents
CS241932B1 (cs) * 1984-05-25 1986-04-17 Jiri Svoboda Způsob výroby substituovaných benzisothiazolin- -3-on-l,1-dioxidů
US4748182A (en) * 1986-03-05 1988-05-31 Merrell Dow Pharmaceuticals Inc. Aromatic 2-aminoalkyl-1,2-benzoisothiazol-3(2H)one-1,1-dioxide derivatives and their use as anti-hypertensive and anxiolytic agents
AU642537B2 (en) * 1990-11-01 1993-10-21 Sanofi 2-saccharinylmethyl aryl carboxylates useful as proteolytic enzyme inhibitors and compositions and method of use thereof
JPH07200419A (ja) * 1993-12-28 1995-08-04 Nec Corp バスインタフェース装置

Also Published As

Publication number Publication date
KR920701203A (ko) 1992-08-11
ES2110414T3 (es) 1998-02-16
IL94278A0 (en) 1991-03-10
KR0183397B1 (ko) 1999-05-01
DE69031656D1 (de) 1997-12-04
SG48298A1 (en) 1998-04-17
FI103111B (fi) 1999-04-30
EP0471756A1 (en) 1992-02-26
NO914217L (no) 1991-10-28
NO914217D0 (no) 1991-10-28
ATE159720T1 (de) 1997-11-15
DK0471756T3 (da) 1998-05-18
EP0471756A4 (en) 1992-04-08
NO300808B1 (no) 1997-07-28
NZ233521A (en) 1992-05-26
IL94278A (en) 1995-03-30
GR1000965B (el) 1993-03-16
MY106202A (en) 1995-03-31
WO1990013549A1 (en) 1990-11-15
PT93959B (pt) 1996-11-29
DE69031656T2 (de) 1998-04-09
AU5664990A (en) 1990-11-29
PT93959A (pt) 1991-01-08
JPH04507095A (ja) 1992-12-10
FI915093A0 (fi) 1991-10-29
AU637614B2 (en) 1993-06-03
GR900100326A (en) 1991-10-10
EP0471756B1 (en) 1997-10-29

Similar Documents

Publication Publication Date Title
FI103111B1 (fi) Menetelmä proteolyyttisen entsyymin inhibiittoreina käyttökelpoisten sakkariinijohdannaisten valmistamiseksi
NO941937L (no) Sakarinderivater som inhiberer proteolytiske enzymer
DE69232929D1 (de) Saccharinderivate als proteolytische Enzyminhibitoren
ATE255589T1 (de) Kristallin form i von clarithromycin
ES530046A0 (es) Procedimiento para la obtencion de acidos quinoloncarboxilicos
FI972308A0 (fi) 2-substituoituja 1,2,5-tiadiatsolidin-3-oni-1,1-dioksideja ja niitä sisältäviä koostumuksia ja menetelmiä niiden käyttämiseksi
DK585984A (da) 1,7-diphenyl-3-methylaza-7-cyan-8-methyl-nonan og salte deraf til anvendelse ved bekaempelse af sygdomme samt fremgangsmaade til fremstilling af saadanne nonanderivater
BG44708A3 (bg) Метод за получаване на спиро-3-хетероазолони
BG90414A (bg) 2-азабицикло (2,2,1)-хепт-5- ен-2-оцетна киселина и нейни производни, метод за получаване и приложението им
ES2082212T3 (es) Nuevos inhibidores de alfa-glucosidasa.
FI103113B1 (fi) Menetelmä proteolyyttisen entsyymin inhibiittoreina käyttökelpoisten sakkariinijohdannaisten valmistamiseksi
NO843273L (no) Fremgangsmaate for fremstilling av alfa-allen-alfa-amino-syrer
FI960489A0 (fi) Menetelmiä proteolyyttisen entsyymin inhibiittoreina käyttökelpoisten sakkariinijohdannaisten ja niiden välituotteiden valmistamiseksi

Legal Events

Date Code Title Description
GB Transfer or assigment of application

Owner name: SANOFI